Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Michel Langlois
Profile
Projects
Publications
Activities
Awards & Distinctions
124
Results
2021
The CCA special issue on cardiovascular markers
Michel Langlois
Päivi Laitinen
Editorial material
2021
Update on apolipoprotein B
Allan Sniderman
Michel Langlois
Christa Cobbaert
A1
Journal Article
in
CURRENT OPINION IN LIPIDOLOGY
2021
2020
Evolving concepts on the management of dyslipidaemia
Olivier S. Descamps
Ann Verhaegen
Fabien Demeure
Michel Langlois
Ernst Rietzschel
Ann Mertens
Johan De Sutter
Caroline Wallemacq
Patrizio Lancellotti
Gui De Backer
et al.
A1
Journal Article
in
ACTA CLINICA BELGICA
2020
How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study
Hélène De Wolf
Michel Langlois
Janne Suvisaari
Kristin M. Aakre
Hannsjörg Baum
Paul Collinson
Christopher J. Duff
Damien Gruson
Angelika Hammerer-Lercher
Kari Pulkki
et al.
A1
Journal Article
in
CLINICA CHIMICA ACTA
2020
Investigations on the clinical utility of apolipoprotein B measurement : a research priority
Michel Langlois
Editorial material
2020
Muscle strength is a major determinant of the blood pressure response to isometric stress testing : the Asklepios population study
Caroline Van daele
Julio Chirinos Medina
Tim De Meyer
Marc De Buyzere
Michel Langlois
Sofie Bekaert
Patrick Segers
Thierry Gillebert
Ernst Rietzschel
A1
Journal Article
in
JOURNAL OF HYPERTENSION
2020
Non-HDL cholesterol or apoB : which to prefer as a target for the prevention of atherosclerotic cardiovascular disease?
Michel Langlois
Allan D. Sniderman
A1
Journal Article
in
CURRENT CARDIOLOGY REPORTS
2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies : consensus-based recommendations from EAS and EFLM
Michel Langlois
Børge G. Nordestgaard
Anne Langsted
M. John Chapman
Kristin M. Aakre
Hannsjörg Baum
Jan Borén
Eric Bruckert
Alberico Catapano
Christa Cobbaert
et al.
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2020
2018
Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis
Simon Degandt
Rémy Coens
Barbara Cauwelier
Helena Devos
Michel Langlois
Jan Emmerechts
A1
Journal Article
in
JOURNAL OF CLINICAL LABORATORY ANALYSIS
2018
Leukocyte telomere length and diet in the apparently healthy, middle-aged Asklepios population
Tim De Meyer
Sofie Bekaert
Marc De Buyzere
Dirk De Bacquer
Michel Langlois
Nitin Shivappa
James R Hébert
Thierry Gillebert
Ernst Rietzschel
Inge Huybrechts
A1
Journal Article
in
SCIENTIFIC REPORTS
2018
Quantifying atherogenic lipoproteins : current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol : a consensus statement from EAS and EFLM
Michel Langlois
M John Chapman
Christa Cobbaert
Samia Mora
Alan T Remaley
Emilio Ros
Gerald F Watts
Jan Borén
Hannsjörg Baum
Eric Bruckert
et al.
A1
Journal Article
in
CLINICAL CHEMISTRY
2018
The role of nutraceuticals in statin intolerant patients
Maciej Banach
Angelo Maria Patti
Rosaria Vincenza Giglio
Arrigo F.G. Cicero
Atanas G. Atanasov
Gani Bajraktari
Eric Bruckert
Olivier Descamps
Dragan M. Djuric
Marat Ezhov
et al.
A1
Journal Article
in
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2018
Which lipids should be analyzed for diagnostic workup and follow-up of patients with hyperlipidemias?
Michel Langlois
Børge G. Nordestgaard
A1
Journal Article
in
CURRENT CARDIOLOGY REPORTS
2018
2017
Are heart failure management recommendations and guidelines followed in laboratory medicine in Europe and North America? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study
Angelika Hammerer-Lercher
Paul O. Collinson
Janne Suvisaari
Robert H. Christenson
Kari Pulkki
Marja P. van Dieijen-Visser
Christopher J. Duff
Hannsjorg Baum
Ana Stavljenic-Rukavina
Kristin M. Aakre
et al.
A2
Journal Article
in
JOURNAL OF APPLIED LABORATORY MEDICINE
2017
Could accreditation bodies facilitate the implementation of medical guidelines in laboratories?
Kristin M. Aakre
Wytze P. Oosterhuis
Shivani Misra
Michel Langlois
Watine Joseph
Patrick J. Twomey
Julian H. Barth
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2017
Lipid-lowering nutraceuticals in clinical practice : position paper from an International Lipid Expert Panel
Arrigo F G Cicero
Alessandro Colletti
Gani Bajraktari
Olivier Descamps
Dragan M Djuric
Marat Ezhov
Zlatko Fras
Niki Katsiki
Michel Langlois
Gustavs Latkovskis
et al.
A1
Journal Article
in
NUTRITION REVIEWS
2017
Obituary : Victor Blaton (1937–2017)
Joris Delanghe
Michel Langlois
Biography
2017
Precision of nonfasting lipid profiles should focus on clinical relevance rather than necessarily obtaining the least variation
Børge G. Nordestgaard
Michel Langlois
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2017
2016
Evaluation of three hemoglobin A1c point-of-care instruments
Marieke Criel
Stijn Jonckheere
Michel Langlois
A1
Journal Article
in
CLINICAL LABORATORY
2016
Fasting is not routinely required for determination of a lipid profile : clinical and laboratory implications including flagging at desirable concentration cut-points : a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G. Nordestgaard
Anne Langsted
Samia Mora
Genovefa Kolovou
Hannsjörg Baum
Eric Bruckert
Gerald F. Watts
Grazyna Sypniewska
Olov Wiklund
Jan Borén
et al.
A1
Journal Article
in
EUROPEAN HEART JOURNAL
2016
Fasting is not routinely required for determination of a lipid profile : clinical and laboratory implications including flagging at desirable concentration cutpoints : a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard
Anne Langsted
Samia Mora
Genovefa Kolovou
Hannsjörg Baum
Eric Bruckert
Gerald F Watts
Grazyna Sypniewska
Olov Wiklund
Jan Borén
et al.
A1
Journal Article
in
CLINICAL CHEMISTRY
2016
The relationship between the metabolic syndrome and arterial wall thickness : a mosaic still to be interpreted
Angelo Scuteri
Oscar H Franco
Majiid AlGhatrif
Jolita Badariene
Sergey Boytsov
Hao-Min Cheng
Chen-Huan Chen
Seong-Woo Choi
Francesco Cucca
Marc De Buyzere
et al.
A1
Journal Article
in
ATHEROSCLEROSIS
2016
Why are clinical practice guidelines not followed?
Julian H. Barth
Shivani Misra
Kristin Moberg Aakre
Michel Langlois
Joseph Watine
Patrick J. Twomey
Wytze P. Oosterhuis
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2016
2015
Bone scan alterations in aromatase inhibitor–treated patients
Frank De Geeter
Annick Van den Bruel
Eveline De Cuypere
Michel Langlois
Editorial material
2015
Proteolysis is a confounding factor in the interpretation of faecal calprotectin
Els Dumoulin
Stephanie Van Biervliet
Michel Langlois
Joris Delanghe
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2015
2013
Accuracy of three automated 25-hydroxyvitamin D assays in hemodialysis patients
Barbara Depreter
Annemieke C Heijboer
Michel Langlois
A1
Journal Article
in
CLINICA CHIMICA ACTA
2013
Critical review of laboratory investigations in clinical practice guidelines : proposals for the description of investigation
Kristin M. Aakre
Michel Langlois
Joseph Watine
Julian H. Barth
Hannsjörg Baum
Paul Collinson
Païvi Laitinen
Wytze P. Oosterhuis
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2013
Genetic aspects of scurvy and the European famine of 1845-1848
Joris Delanghe
Marc De Buyzere
Marijn Speeckaert
Michel Langlois
A1
Journal Article
in
NUTRIENTS
2013
HDL-gerichte therapieën: behandeling van een risicofactor of 'make-up' van een risicomerker?
Marc De Buyzere
Ernst Rietzschel
Michel Langlois
Bookchapter
in
Atherosclerose-atherotrombose 2013
2013
Pseudonephritis is associated with high urinary osmolality and high specific gravity in adolescent soccer players
Stephanie Van Biervliet
Jean Pierre Van Biervliet
KAREL WATTEYNE
Michel Langlois
David Bernard
Johan Vande Walle
A1
Journal Article
in
PEDIATRIC EXERCISE SCIENCE
2013
Traitements axés sur les HDL: traitement d'un facteur de risque ou maquillage d'un marqueur de risque?
Marc De Buyzere
Ernst Rietzschel
Michel Langlois
Bookchapter
in
Athérosclerose-athérothrombose 2013
2013
Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation: is time still on our side?
Michel Langlois
Joris Delanghe
Marc De Buyzere
Ernst Rietzschel
Dirk De Bacquer
A1
Journal Article
in
ATHEROSCLEROSIS
2013
2012
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels
Philippe Froguel
Ndeye Coumba Ndiaye
Amélie Bonnefond
Nabila Bouatia-Naji
Aurélie Dechaume
Gérard Siest
Bernard Herbeth
Mario Falchi
Leonardo Bottolo
Rosa-Maria Guéant-Rodriguez
et al.
A1
Journal Article
in
PLOS ONE
2012
Human plasma protein polymorphisms and the persistence of cultural diversity
Joris Delanghe
Marijn Speeckaert
Marc De Buyzere
Michel Langlois
Mathieu Torck
A1
Journal Article
in
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
2012
Is it time to apply genographics in medical diagnosis?
Michel Langlois
Joris Delanghe
Editorial material
2012
Laboratory approaches for predicting and managing the risk of cardiovascular disease : postanalytical opportunities of lipid and lipoprotein testing
Michel Langlois
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2012
The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients
Reinhart Speeckaert
Lieve Brochez
Jo Lambert
Nanja van Geel
Marijn Speeckaert
LAURENS CLAEYS
Michel Langlois
C Van Laer
Patrick Peeters
Joris Delanghe
A1
Journal Article
in
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2012
2011
Haptoglobin polymorphism: a key factor in the proatherogenic role of B cells?
Joris Delanghe
Michel Langlois
Marc De Buyzere
A1
Journal Article
in
ATHEROSCLEROSIS
2011
The relationship between diet and subclinical atherosclerosis : results from the Asklepios study
Liesbeth Hoebeeck
Ernst Rietzschel
Michel Langlois
Marc De Buyzere
Dirk De Bacquer
Gui De Backer
Lea Maes
Thierry Gillebert
Inge Huybrechts
A1
Journal Article
in
EUROPEAN JOURNAL OF CLINICAL NUTRITION
2011
Vitamin C deficiency: more than just a nutritional disorder
Joris Delanghe
Michel Langlois
Marc De Buyzere
Na Na
Jin Ouyang
Marijn Speeckaert
Mathieu Torck
Editorial material
2011
2010
Evaluation of standard and advanced preprocessing methods for the univariate analysis of blood serum 1H-NMR spectra
Tim De Meyer
Davy Sinnaeve
Björn Van Gasse
Ernst Rietzschel
Marc De Buyzere
Michel Langlois
Sofie Bekaert
José Martins
Wim Van Criekinge
A1
Journal Article
in
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
2010
2009
Plasma vitamin C for predicting cardiovascular disease: more than a nutritional biomarker
Michel Langlois
Marc De Buyzere
Joris Delanghe
Editorial material
2009
Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients
Eline Verhoye
Annick Van den Bruel
Joris Delanghe
Evi Debruyne
Michel Langlois
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2009
Systemic telomere length and preclinical atherosclerosis : the Asklepios study
Tim De Meyer
Ernst Rietzschel
Marc De Buyzere
Michel Langlois
Dirk De Bacquer
Patrick Segers
PIET VAN DAMME
Gui De Backer
Patric Van Oostveldt
Wim Van Criekinge
et al.
A1
Journal Article
in
EUROPEAN HEART JOURNAL
2009
2008
Femoral Plaques Confound the Association of Circulating Oxidized 951 Low-density Lipoprotein with Carotid Atherosclerosis in a General Population Aged 35-55 Years (Asklepios Study)
Ernst Rietzschel
Michel Langlois
Marc De Buyzere
Dirk De Bacquer
Sofie Bekaert
Victor Blaton
Gui De Backer
Thierry Gillebert
C3
Conference
2008
Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years - The Asklepios study
Michel Langlois
Ernst Rietzschel
Marc De Buyzere
Dirk De Bacquer
Sofie Bekaert
V BLATON
Gui De Backer
Thierry Gillebert
A1
Journal Article
in
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
2008
Liquid Assets.
J VAN BIERVLIET
KAREL WATTEYNE
P DHOOGHE
Stephanie Van Biervliet
Dirk Bernard
Michel Langlois
A4
Journal Article
in
Medicine matters UEFA
2008
Lower red blood cell counts in middle-aged subjects with shorter peripheral blood leukocyte telomere length
Tim De Meyer
Marc De Buyzere
Michel Langlois
Ernst Rietzschel
Peter Cassiman
Dirk De Bacquer
Patric Van Oostveldt
Gui De Backer
Thierry Gillebert
Wim Van Criekinge
et al.
A1
Journal Article
in
AGING CELL
2008
Oral vitamin C administration increases lipid peroxidation in hemodialysis patients
An S. De Vriese
Danielle Borrey
Els Mahieu
Ilse Claeys
Lut Stevens
Ann Vanhaeverbeke
Mieke Roelens
Michel Langlois
A1
Journal Article
in
NEPHRON CLINICAL PRACTICE
2008
Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations
Ernst Rietzschel
Michel Langlois
Marc De Buyzere
Patrick Segers
Dirk De Bacquer
Sofie Bekaert
Luc Cooman
Patric Van Oostveldt
Pascal Verdonck
Gui De Backer
et al.
A1
Journal Article
in
HYPERTENSION
2008
2007
Oral contraceptives cause major C-reactive protein rises in the female general population
Ernst Rietzschel
Marc De Buyzere
D DE BAQUER
Michel Langlois
Sofie Bekaert
Patrick Segers
P VAN DAMME
Pascal Verdonck
Gui De Backer
Thierry Gillebert
C3
Conference
2007
Rationale, design, methods and baseline characteristics of the Asklepios Study
Ernst Rietzschel
Marc De Buyzere
Sofie Bekaert
Patrick Segers
Dirk De Bacquer
Luc Cooman
PIET VAN DAMME
Peter Cassiman
Michel Langlois
Patric Van Oostveldt
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
2007
Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease
Sofie Bekaert
Tim De Meyer
Ernst Rietzschel
Marc De Buyzere
Dirk De Bacquer
Michel Langlois
Patrick Segers
Luc Cooman
Piet Van Damme
Peter Cassiman
et al.
A1
Journal Article
in
AGING CELL
2007
Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphism
Joris Delanghe
Michel Langlois
Marc De Buyzere
Mathieu Torck
A1
Journal Article
in
CLINICAL CHEMISTRY
2007
2006
Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants
Johan De Sutter
René Tavernier
Dirk De Bacquer
Marc De Buyzere
Nico Van de Veire
Luc Jordaens
K Matthys
D Bernard
Michel Langlois
Gui De Backer
A1
Journal Article
in
INTERNATIONAL JOURNAL OF CARDIOLOGY
2006
Haptoglobin polymorphism in patients with preeclampsia
Herman Depypere
Michel Langlois
Joris Delanghe
Marleen Temmerman
Marc Dhont
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2006
Implementation of the European guidelines on CVD prevention: is it time to qualify the "qualifiers"? Results from the ASKLEPIOS study
Ernst Rietzschel
Marc De Buyzere
Michel Langlois
Dirk De Bacquer
Thierry Gillebert
Gui De Backer
C3
Conference
2006
Is there a "Primus inter pares" of ATP-III metabolic syndrome components in predicting subclinical cardiovascular damage?
Ernst Rietzschel
Marc De Buyzere
Dirk De Bacquer
Sofie Bekaert
Patrick Segers
Michel Langlois
Gui De Backer
Thierry Gillebert
C3
Conference
2006
Maximum oxygen uptake at peak exercise in elderly patients with coronary artery disease and preserved left ventricular function: The role of inflammation on top of tissue Doppler-derived systolic and diastolic function
Nico Van de Veire
Olivier De Winter
Jan Philippé
Marc De Buyzere
Dirk Bernard
Michel Langlois
Thierry Gillebert
Johan De Sutter
A1
Journal Article
in
AMERICAN HEART JOURNAL
2006
Neurohumoral and inflammatory activation in patients with coronary artery disease treated with statins
Nico Van de Veire
Jan Philippé
Olivier De Winter
Michel Langlois
D BERNARD
Johan De Sutter
Editorial material
2006
What drives (elevated) high-sensitive CRP in the general population?
Ernst Rietzschel
Marc De Buyzere
Michel Langlois
Dirk De Bacquer
Sofie Bekaert
Patrick Segers
Gui De Backer
Thierry Gillebert
C3
Conference
2006
2005
Metabolic syndrome and cardiac trophism. Results from the Asklepios Study in 2528 apparently healthy 35-55 year old subjects
ER RLETZSCHEL
Marc De Buyzere
Dirk De Bacquer
Michel Langlois
Gui De Backer
Thierry Gillebert
C3
Conference
2005
Metabolic syndrome, a map of the cardiovascular damage. Results from the Asklepios Study in 2528 apparently healthy 35-55 year old subjects
Ernst Rietzschel
Marc De Buyzere
Dirk De Bacquer
Michel Langlois
S BEKAERT
Gui De Backer
Thierry Gillebert
C3
Conference
2005
Neurohumoral activation: the missing link in statin treated patients with persistent inflammatory activation?
Nico Van de Veire
Johan De Sutter
Marc De Buyzere
Jan Philippé
Dirk Bernard
Michel Langlois
AK ASCOOP
Thierry Gillebert
C3
Conference
2005
Quantitative HPLC analysis of diuron and three metabolites in human serum and urine
Daniëlle Borrey
Harmen Reyngoudt
P Van Saet
Veronique Engelrelst
Dirk Bernard
Michel Langlois
C1
Conference
2005
2004
Arterial wave reflection: a factor contributing to heart failure in elderly patients with coronary artery disease ?
Patrick Segers
Johan De Sutter
Nico Van de Veire
Julie De Backer
S RABBEN
D BERNARD
Michel Langlois
Marc De Buyzere
Pascal Verdonck
Thierry Gillebert
Other
2004
Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients
Youri Taes
Joris Delanghe
Dirk De Bacquer
Michel Langlois
L STEVENS
I GEEROLF
Norbert Lameire
AS DE VRIESE
A1
Journal Article
in
KIDNEY INTERNATIONAL
2004
Haptoglobin polymorphisms and iron homeostasis in health and in disease
Hans Van Vlierberghe
Michel Langlois
Joris Delanghe
A1
Journal Article
in
CLINICA CHIMICA ACTA
2004
Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism
Annelies Brouwers
Michel Langlois
Joris Delanghe
Johan Billiet
Marc De Buyzere
Raf Vercaemst
Ernst Rietzschel
Dirk Bernard
Victor Blaton
A1
Journal Article
in
ATHEROSCLEROSIS
2004
2003
Serum uric acid in hypertensive patients with and without peripheral arterial disease
Michel Langlois
Dirk De Bacquer
Daniel Duprez
Marc De Buyzere
Joris Delanghe
V BLATON
A1
Journal Article
in
ATHEROSCLEROSIS
2003
The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism
D BERNARD
Armand Christophe
Joris Delanghe
Michel Langlois
Marc De Buyzere
Frank Comhaire
A1
Journal Article
in
REDOX REPORT
2003
2002
Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease.
Joris Delanghe
Michel Langlois
Dirk De Bacquer
Rudolf Mak
P CAPEL
LV VAN RENTERGHEM
Gui De Backer
A1
Journal Article
in
ATHEROSCLEROSIS
2002
Effect of transferrin polymorphism on the metabolism of vitamin C in Zimbabwean adults.
I KASVOSVE
Joris Delanghe
Z GOMO
IT GANGAIDZO
H KHUMALO
Michel Langlois
VM MOYO
T SAUNGWEME
E MVUNDURA
JR BOELAERT
et al.
A1
Journal Article
in
AMERICAN JOURNAL OF CLINICAL NUTRITION
2002
Haptoglobin polymorphism and body iron stores.
Joris Delanghe
Michel Langlois
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2002
Performance of urinary flow cytometry in predicting outcome of urine cultures.
Joris Delanghe
Michel Langlois
B WUYTS
Marc De Buyzere
A1
Journal Article
in
JOURNAL OF CLINICAL MICROBIOLOGY
2002
Urinezuur en claudicatio bij hypertensie en perifeer arterieel lijden
Michel Langlois
Daniel Duprez
A4
Journal Article
in
BLOEDVATEN HART LONGEN
2002
2001
Automated flow cytometric analysis of cerebrospinal fluid.
JT VAN ACKER
Joris Delanghe
Michel Langlois
Youri Taes
Marc De Buyzere
Alain Verstraete
A1
Journal Article
in
CLINICAL CHEMISTRY
2001
Haptoglobin
Joris Delanghe
Michel Langlois
Bookchapter
in
Encyclopedia of molecular medicine (ed : T. Creighton); Wiley and Sons, New York 2001
2001
Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients
Hans Van Vlierberghe
Michel Langlois
Joris Delanghe
Y HORSMANS
P MICHIELSEN
J HENRION
R CARTUYVELS
J BILLIET
Martine De Vos
Geert Leroux-Roels
A1
Journal Article
in
JOURNAL OF HEPATOLOGY
2001
Haptoglobin polymorphism as a risk factor for coronary heart disease mortality.
Dirk De Bacquer
Gui De Backer
Michel Langlois
Joris Delanghe
H KESTELOOT
M KORNITZER
A1
Journal Article
in
ATHEROSCLEROSIS
2001
Hemopexin: a review of biological aspects and the role in laboratory medicine.
Joris Delanghe
Michel Langlois
A1
Journal Article
in
CLINICA CHIMICA ACTA
2001
Iron status and the outcome of HIV infection: an overview.
VR GORDEUK
Joris Delanghe
Michel Langlois
JR BOELAERT
A1
Journal Article
in
JOURNAL OF CLINICAL VIROLOGY
2001
Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis (with comment: Vitamin C depletion linked to inflammation in peripheral artery disease. M. Larkin Lancet, 357, 2001, 1184).
Michel Langlois
Daniel Duprez
Joris Delanghe
Marc De Buyzere
Denis Clement
A1
Journal Article
in
CIRCULATION
2001
2000
A new method for fast haptoglobin phenotyping and hemoglobin binding capacity calculation based on capillary zone electrophoresis.
B WUYTS
Joris Delanghe
I KASVOSVE
Michel Langlois
Marc De Buyzere
J JANSSENS
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2000
Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatography
Joris Delanghe
K Allcock
Michel Langlois
LAURENS CLAEYS
Marc De Buyzere
A1
Journal Article
in
CLINICA CHIMICA ACTA
2000
Haptoglobin 1F allele frequency is high among indigenous populations in the state of Durango, Mexico
Joris Delanghe
Michel Langlois
C Alvarado Esquivel
H De Haene
Marc De Buyzere
A1
Journal Article
in
HUMAN HEREDITY
2000
Oxidative stress and atherosclerosis.
Michel Langlois
A2
Journal Article
in
EVERYDAY PROBLEMS IN CLINICAL CARDIOLOGY, EXCERPTA MEDICA, ALMERE
2000
The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males.
Michel Langlois
ME MARTIN
JR BOELAERT
C BEAUMONT
Youri Taes
Marc De Buyzere
DR BERNARD
HM NEELS
Joris Delanghe
A1
Journal Article
in
CLINICAL CHEMISTRY
2000
1999
Appication of Western-blotting technique with chemiluminescence imaging to the study of haptoglobin type and haptoglobin complexes.
Jin Ouyang
J DELANGHE
Willy Baeyens
Michel Langlois
A2
Journal Article
in
BIOMEDICAL CHROMATOGRAPHY
1999
Automated flow cytometry compared with an automated dipstick reader for urinalysis.
Michel Langlois
JR DELANGHE
SR STEYAERT
Karel Everaert
Marc De Buyzere
A1
Journal Article
in
CLINICAL CHEMISTRY
1999
Haptoglobin polymorphism and peripheral arterial occlusive disease
Joris Delanghe
Michel Langlois
Daniel Duprez
Marc De Buyzere
Denis Clement
A1
Journal Article
in
ATHEROSCLEROSIS
1999
Reference values of serum IgA subclasses in Caucasian adults by immunonephelometry.
M BERTH
J DELANGHE
Michel Langlois
Marc De Buyzere
A1
Journal Article
in
CLINICAL CHEMISTRY
1999
1998
Application of Western-blotting technique with chemiluminescence imaging to the study of haptoglobin type and haptoglobin complexes.
Jin Ouyang
Joris Delanghe
Willy Baeyens
Michel Langlois
A1
Journal Article
in
ANALYTICA CHIMICA ACTA
1998
Application of western-blotting technique with chemiluminisence imaging to the study of haptoglobin type and haptoglobin complexes
Jin Ouyang
Joris Delanghe
W BAEYENS
Michel Langlois
A2
Journal Article
in
Journal of Biomedical chromatography
1998
Congenital anhaptoglobinemia versus acquired hypohaptoglobinemia.
Joris Delanghe
Michel Langlois
Marc De Buyzere
A1
Journal Article
in
BLOOD
1998
Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes.
Joris Delanghe
Michel Langlois
OY JIN
Geert Claeys
Marc De Buyzere
B WUYTS
A1
Journal Article
in
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
1998
Haptoglobin polymorphism, iron metabolism and mortality in HIV infection.
Joris Delanghe
Michel Langlois
JR BOELAERT
J VAN ACKER
F VAN WANZEELE
G VAN DER GROEN
R HEMMER
C VERHOFSTEDE
Marc De Buyzere
Dirk De Bacquer
et al.
A1
Journal Article
in
AIDS
1998
Serum creatine kinase activity is not a reliable marker for muscle damage in conditions associated with low extracellular glutathione concentration
J Gunst
Michel Langlois
Joris Delanghe
Marc De Buyzere
Geert Leroux-Roels
A1
Journal Article
in
CLINICAL CHEMISTRY
1998
1997
Difference in hemoglobin-binding ability of polymers among haptoglobin phenotypes - Response.
Joris Delanghe
Michel Langlois
A1
Journal Article
in
CLINICAL CHEMISTRY
1997
Difficulties in evaluating urinalysis following combined pancreas–kidney transplantation
Dirk Bernard
Joris Delanghe
Michel Langlois
A1
Journal Article
in
ANNALS OF CLINICAL BIOCHEMISTRY
1997
Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type - Binding of haptoglobin to the B-cell lectin CD22.
Michel Langlois
Joris Delanghe
Jan Philippé
Jin Ouyang
D BERNARD
Marc De Buyzere
G VANNOOTEN
Geert Leroux-Roels
A1
Journal Article
in
EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY
1997
Effect of haptoglobin on the metabolism of vitamin C.
Michel Langlois
Joris Delanghe
Marc De Buyzere
DR BERNARD
Jin Ouyang
A1
Journal Article
in
AMERICAN JOURNAL OF CLINICAL NUTRITION
1997
Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infaction
D BERNARD
Michel Langlois
Marc De Buyzere
Joris Delanghe
Bookchapter
in
Advances in critical care testing (List WF, Mueller MM, McQueeen MJ, eds). Springer Verlag, Berlin-Heidelberg-New York 1997:p. 86-87
1997
Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infarction.
DR BERNARD
Michel Langlois
Joris Delanghe
Marc De Buyzere
A1
Journal Article
in
EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY
1997
Functional and clinical investigations on the haptoglobin polymorphism in man
Michel Langlois
Joris Delanghe
Dissertation
1997
Haptoglobin polymorphism and hypertension in the elderly
J DELANGHE
Daniel Duprez
Marc De Buyzere
Michel Langlois
H VANDENBUSSCHE
Denis Clement
A2
Journal Article
in
American Journal College, 10, 58A
1997
Haptoglobin polymorphism and peripheral arterial occlusive disease
Michel Langlois
Joris Delanghe
Daniel Duprez
Marc De Buyzere
D Bernard
C3
Conference
1997
Haptoglobin polymorphism as a cardiovascular risk factor
J DELANGHE
Michel Langlois
Marc De Buyzere
Daniel Duprez
[0-9]{2}
1997
Haptoglobin polymorphism as a risk factor in cardiovascular disease
Joris Delanghe
Michel Langlois
Marc De Buyzere
Daniel Duprez
Bookchapter
in
Biologie prospective -Comptes rendus du 9e colloque de Pont-à-Mousson. John Libbey Eurotext, Paris 1997
1997
Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery
Joris Delanghe
Bernard Cambier
Michel Langlois
Marc De Buyzere
Hugo Neels
Dirk De Bacquer
Philippe Van Cauwelaert
A1
Journal Article
in
ATHEROSCLEROSIS
1997
Vitamin D binding protein polymorphism and polymetabolic syndrome in essential hypertension
J Delanghe
Denis Clement
Daniel Duprez
Marc De Buyzere
Michel Langlois
A2
Journal Article
in
JOURNAL OF HYPERTENSION
1997
1996
Biological and clinical significance of haptoglobin polymorphism in humans.
Michel Langlois
Joris Delanghe
A1
Journal Article
in
CLINICAL CHEMISTRY
1996
Reference values for immunoglobulin A are determined by haptoglobin polymorphism
Michel Langlois
Joris Delanghe
Marc De Buyzere
A2
Journal Article
in
CLINICAL CHEMISTRY
1996
Relation between serum IgA concentration and haptoglobin type.
Michel Langlois
Joris Delanghe
Marc De Buyzere
A1
Journal Article
in
CLINICAL CHEMISTRY
1996
1994
Posttranslational heterogeneity of bone alkaline-phosphatase in metabolic bone-disease.
Michel Langlois
Joris Delanghe
Jean Kaufman
Marc De Buyzere
MJ VANHOECKE
Geert Leroux-Roels
A1
Journal Article
in
EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY
1994
1993
THE IMMUNOPHENOTYPE OF EWINGS-SARCOMA - AN IMMUNOHISTOCHEMICAL ANALYSIS.
AM DIERICK
Hendrik Roels
Michel Langlois
A1
Journal Article
in
PATHOLOGY RESEARCH AND PRACTICE
1993
THE PROGNOSTIC-SIGNIFICANCE OF THE DNA CONTENT IN EWINGS-SARCOMA - A RETROSPECTIVE CYTOPHOTOMETRIC AND FLOW CYTOMETRIC STUDY.
AM DIERICK
Michel Langlois
P VANOOSTVELDT
Hendrik Roels
A1
Journal Article
in
HISTOPATHOLOGY
1993
1992
GLYCATION OF HUMAN TISSUE AND SERUM CREATINE-KINASE.
Michel Langlois
Joris Delanghe
Marc De Buyzere
Geert Leroux-Roels
A1
Journal Article
in
CLINICA CHIMICA ACTA
1992
Glycation of human tissue and serum creatine kinase
Michel Langlois
Joris Delanghe
Marc De Buyzere
Geert Leroux-Roels
A2
Journal Article
in
Clin. Chim. Acta, 211
1992
1991
A new method for calculation of infarct size making use of cumulative myoglobin release.
J DELANGHE
Marc De Buyzere
Michel Langlois
H LIEVENS
Denis Clement
A2
Journal Article
in
ACTA CARDIOLOGICA
1991
Monitoring of haptoglobin concentration during the early phase of acute myocardial infarction.
Michel Langlois
J DELANGHE
Marc De Buyzere
L CLAEYS
Denis Clement
A2
Journal Article
in
ACTA CARDIOLOGICA
1991
Effect of haptoglobin polymorphism on the outcome of HIV-1 infection. Biometais 1997; 10:227-236.
Joris Delanghe
Michel Langlois
J VAN ACKER
P VAN WANZEELE
J BOELAERT
[0-9]{2}
Glycosylated and non-glycosylated isoforms of creatine kinase. Proc. IX European Congress Clin. Chemistry, Diagnostyka Laboratoryjna, 1991, 27, (Suppl), p. 102.
Michel Langlois
Joris Delanghe
Marc De Buyzere
C1
Conference
Haptoglobin polymorphism and progression of human immune deficiency syndrome. AIDS 1998;12:1027-1032.
Joris Delanghe
J VAN ACKER
R HEMMER
Michel Langlois
G VAN DER GROEN
Chris Verhofstede
Filip Van Wanzeele
D DE BACQUER
Jean Plum
[0-9]{2}